AiCuris Anti-infective Cures AG: AiCuris Announces Expansion of its Collaboration with Lysando with a Focus on Diabetic Foot Infections
New project started to jointly develop Artilysin(R)s as innovative novel treatment option for infected, chronic wounds such as diabetic foot infections, the most common complication of diabetes mellitusExpansion
Krung Thep Mahanakhon Nordrhein Westfalen United States Lysando Gmb Katja Woestenhemke Kostenloser Wertpapierhandel
Source: finanznachrichten.de